Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.
Details
Serval ID
serval:BIB_155E1BF5993B
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.
Journal
Annals of internal medicine
Working group(s)
CoviCare Study Team
Contributor(s)
Aebischer Perone S., Alcoba G., Lador F., Kopp G., Benzakour L., Grira M., Innaurato G., Socquet J., Spechbach H., Salamun J., Jacquerioz F., Agoritsas T., Allali G., Chevallier-Lugon C., Baggio S., Carnino L., Lab B., Sandoval J., Stringhini S., Chopard P., Regard S., Genecand C., Koegler F., Lebowitz D., Tardin A.
ISSN
1539-3704 (Electronic)
ISSN-L
0003-4819
Publication state
Published
Issued date
09/2021
Peer-reviewed
Oui
Volume
174
Number
9
Pages
1252-1260
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months.
To characterize symptoms 7 to 9 months after diagnosis of COVID-19.
Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis.
From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were followed by CoviCare, a virtual, clinical, outpatient follow-up program. Persons were contacted again at 30 to 45 days and 7 to 9 months from diagnosis.
Persons who were a part of the CoviCare program from 18 March to 15 May 2020.
A standardized interview of symptoms consistent with COVID-19, with grading of intensity.
Of the 629 participants in the study who completed the baseline interviews, 410 completed follow-up at 7 to 9 months after COVID-19 diagnosis; 39.0% reported residual symptoms. Fatigue (20.7%) was the most common symptom reported, followed by loss of taste or smell (16.8%), dyspnea (11.7%), and headache (10.0%).
Limitations include generalizability and missing data for 34.8% of participants.
Residual symptoms after SARS-CoV-2 infection are common among otherwise young and healthy persons followed in an outpatient setting. These findings contribute to the recognition of long-term effects in a disease mostly counted by its death toll to date by promoting communication on postacute sequelae of SARS-CoV-2 and encouraging physicians to continue long-term monitoring of their patients.
None.
To characterize symptoms 7 to 9 months after diagnosis of COVID-19.
Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis.
From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were followed by CoviCare, a virtual, clinical, outpatient follow-up program. Persons were contacted again at 30 to 45 days and 7 to 9 months from diagnosis.
Persons who were a part of the CoviCare program from 18 March to 15 May 2020.
A standardized interview of symptoms consistent with COVID-19, with grading of intensity.
Of the 629 participants in the study who completed the baseline interviews, 410 completed follow-up at 7 to 9 months after COVID-19 diagnosis; 39.0% reported residual symptoms. Fatigue (20.7%) was the most common symptom reported, followed by loss of taste or smell (16.8%), dyspnea (11.7%), and headache (10.0%).
Limitations include generalizability and missing data for 34.8% of participants.
Residual symptoms after SARS-CoV-2 infection are common among otherwise young and healthy persons followed in an outpatient setting. These findings contribute to the recognition of long-term effects in a disease mostly counted by its death toll to date by promoting communication on postacute sequelae of SARS-CoV-2 and encouraging physicians to continue long-term monitoring of their patients.
None.
Keywords
Adolescent, Adult, Ambulatory Care, COVID-19/complications, COVID-19/diagnosis, COVID-19/epidemiology, Dyspnea/virology, Fatigue/virology, Female, Headache/virology, Health Surveys/methods, Humans, Interviews as Topic, Male, Middle Aged, Olfaction Disorders/virology, Prevalence, SARS-CoV-2, Self Report, Telephone, Time Factors, Young Adult, Post-Acute COVID-19 Syndrome
Pubmed
Web of science
Create date
11/10/2023 7:10
Last modification date
12/10/2023 5:59
Usage data
